About this trial
The hypothesis of this study is to investigate cardiorespiratory and renal complications in patients under general anesthesia undergoing POEM surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients diagnosed with achalasia and suitable for POEM treatment by gastroenterology physicians
ASA 1-3
Between the ages of 18-80
Disqualifiers
Those with a known history of active lung infection, advanced COPD, or respiratory failure
Patients with EF below 40%, severe ischemic heart failure, presence of valve disease
Those with bleeding diathesis and severe thrombocytopenia (limit 30-50 thousand)
severe kidney dysfunction
Trial population
In this retrospective cohort study, 50 patients diagnosed with achalasia who applied to the Gastroenterology department of Ümraniye Training and Research Hospital between October 2021 and February 2024 and were indicated for POEM treatment will be included.
Trial design
Cohort
Retrospective
Treatments tested in this trial
MUST malnutrition score
Other interventionMUST malnutrition score
Treatment groups
Trial outcomes
Primary outcomes
cardiorespiratory advers events
hypercapnia (above 45mmHg)
postoperative renal complications
serum creatinine 0.3 mg/dL rise
Secondary outcomes
Malnutrition condition
serum albumin (3.4 to 5.4 g/dL)
escart score
weight loss ( \<5kg to10kg\>)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.